The US White House on Friday sent to Congress President Joe Biden’s discretionary funding request for the fiscal year 2022.
President Biden proposed huge increases for many federal research agencies as part of a $118 billion boost in domestic spending.
As Joe Biden's first budget request to Congress as President, it offers a look at his priorities on healthcare and education, with increases in discretionary - or optional spending - across the board. A proposal detailing mandatory spending requests - which includes Medicaid and Medicare - will come later, said White House officials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze